Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Apr-23 7:24 PM View:  | Cymabay Therapeutics, Inc. (CBAY) | 17-Apr-23 | Option Exercise | 112,219 | $4.37 | $490,397.00 | 561% 20.0K to 132.22K | |
| 17-Apr-23 7:24 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 17-Apr-23 | Option Sale | 112,219 | $9.54 | $1,070,540.00 | (85%) 132.22K to 20.0K | |
| 17-Apr-23 7:24 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 13-Apr-23 | Option Exercise | 7,781 | $4.37 | $34,003.00 | 39% 20.0K to 27.78K | |
| 17-Apr-23 7:24 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 13-Apr-23 | Option Sale | 7,781 | $8.98 | $69,880.40 | (28%) 27.78K to 20.0K | |
| 30-Mar-23 5:39 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 28-Mar-23 | Option Exercise | 100 | $4.37 | $437.00 | < 1% 20.0K to 20.1K | |
| 30-Mar-23 5:39 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 28-Mar-23 | Option Sale | 100 | $8.98 | $898.50 | (< 1%) 20.1K to 20.0K | |
| 20-Jan-22 4:35 PM View: | Cymabay Therapeutics, Inc. (CBAY) | 19-Jan-22 | Market Purchase | 20,000 | $3.04 | $60,800.00 | 100% 0 to 20.0K | 7% |
| 12-Jul-17 4:05 PM View: | Larimar Therapeutics, Inc. (LRMR) | 11-Jul-17 | Market Purchase | 10,000 | $3.39 | $33,900.00 | 87% 11.44K to 21.44K | 281% |
| 11-May-17 6:59 PM View: | Larimar Therapeutics, Inc. (LRMR) | 11-May-17 | Market Purchase | 9,800 | $4.40 | $43,120.00 | 596% 1.64K to 11.44K | 193% |
| 11-May-17 6:59 PM View: | Larimar Therapeutics, Inc. (LRMR) | 10-May-17 | Market Purchase | 200 | $4.40 | $880.00 | 14% 1.44K to 1.64K | 193% |
| 17-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 17-Sep-15 | Option Exercise | 9,142 | $1.57 | $14,352.90 | 100% 0 to 9.14K | |
| 17-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 17-Sep-15 | Market Option Sale | 9,142 | $40.00 | $365,680.00 | (100%) 9.14K to 0 | 69% |
| 17-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 15-Sep-15 | Option Exercise | 30,265 | $1.57 | $47,516.10 | 100% 0 to 30.27K | |
| 17-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 15-Sep-15 | Market Option Sale | 30,265 | $40.00 | $1,210,600.00 | (100%) 30.27K to 0 | 69% |
| 16-Sep-15 9:48 PM View: | Larimar Therapeutics, Inc. (LRMR) | 14-Sep-15 | Option Exercise | 593 | $1.57 | $931.01 | 100% 0 to 0.59K | |
| 16-Sep-15 9:48 PM View: | Larimar Therapeutics, Inc. (LRMR) | 14-Sep-15 | Market Option Sale | 593 | $40.00 | $23,720.00 | (100%) 0.59K to 0 | 69% |
| 26-Mar-09 1:41 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 24-Mar-09 | Grant | 10,000 | $2.65 | $26,500.00 | 66% 15.2K to 25.2K | (89%) |